Connaughton Bernadette
Director
1 company
Insider Signal Score
49
AverageTrades Analyzed
5
12M Win Rate
-
Avg 3M Return
+1.5%
Avg 12M Return
-
Connaughton Bernadette is a Director at Halozyme Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 9 sells.
Estimated insider holdings value: $3.6M based on current market prices.
Holdings by Company
HALOJun 1, 2026
Current Shares43.7K
Value$3.62M
Net Activity-12,454
Bought: 0Sold: 12.5K
Transaction History
Showing 6 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | HALO Halozyme Therapeutics, Inc. | Director | Sell | 1,625 | $66.21 | $107,591.25 | -3.6% | - | - | |
| Jan 5, 2026 | HALO Halozyme Therapeutics, Inc. | Director | Sell | 2,000 | $70.25 | $140,500.00 | -4.7% | -11.4% | - | |
| Dec 1, 2025 | HALO Halozyme Therapeutics, Inc. | Director | Sell | 829 | $71.60 | $59,356.40 | -1.9% | +2.6% | - | |
| Nov 10, 2025 | HALO Halozyme Therapeutics, Inc. | Director | Sell | 2,000 | $68.48 | $136,960.00 | -4.4% | +18.3% | - | |
| Oct 1, 2025 | HALO Halozyme Therapeutics, Inc. | Director | Sell | 2,000 | $75.24 | $150,481.00 | -2.2% | -9.7% | - | |
| Sep 2, 2025 | HALO Halozyme Therapeutics, Inc. | Director | Sell | 4,000 | $73.68 | $294,736.24 | -2.7% | -7.1% | - |